Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Clin |
RCV004595648 | SCV005088249 | likely benign | Hereditary thrombocytopenia and hematologic cancer predisposition syndrome | 2024-06-24 | reviewed by expert panel | curation | NM_001754.5(RUNX1):c.613+14C>G is an intronic variant. This variant is absent from gnomAD v2.1.1 (mean depth of coverage > 60) and from gnomAD v3.1.1 (mean depth of coverage 30) (PM2_Supporting). It is not predicted by SpliceAI to impact splicing (≤0.20). In addition, it occurs at a nucleotide that is not conserved as shown by phyloP100 (0.09) (BP4, BP7). In summary, this variant meets criteria to be classified as likely benign. ACMG/AMP criteria applied, as specified by the Myeloid Malignancy Variant Curation Expert Panel for RUNX1: BP4, BP7, PM2_supporting. |
Labcorp Genetics |
RCV002129346 | SCV002409732 | likely benign | Hereditary thrombocytopenia and hematological cancer predisposition syndrome associated with RUNX1 | 2022-05-20 | criteria provided, single submitter | clinical testing |